Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
5 Chiefs That Changed Our Opinion on Film - 2Find the Mysteries of Effective Objective Setting: Transforming Dreams into Feasible Targets
- 3Instructions to Decide the Best SUV Size for Seniors
- 4Zelensky names spy chief to head presidential office after corruption row
- 5Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises
- Which Brilliant Home Gadget Can't You Reside Without?
- A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- Shrewd Home Gadgets to Save Energy
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- How to watch Dick Clark’s New Year’s Rockin’ Eve with Ryan Seacrest: Start time, TV channel, performers and more
- Grasping the Course of Evacuation and Extradition in U.S. Migration
- ‘Wicked: For Good’ streaming release — How to watch the sequel starring Ariana Grande and Cynthia Erivo
- Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- Feeling wonder every day improves our health. Here’s how to do it.
